Sepsis & infection

Impact of Short-Acting Beta-Blockers on the Outcomes of Patients With Septic Shock: A Systematic Review and Meta-Analysis

Crit Care MedPublished Systematic review and meta-analysis of randomised trials

Pooled result · 28-day mortalityResult — go to the resultRelative risk 0.76 95% CI 0.62–0.93

Authors' conclusion

In patients with septic shock, short-acting beta-blockers may improve survival and reduce new-onset tachyarrhythmias.

Study context

Population
Adults with septic shock
Participants
1,170 adults · 12 randomized controlled trials (RCTs)
Comparison
Short-acting beta-blockers vs usual care
Outcome
28-day mortality
Follow-up
28 days

Pooled result

As reported in the abstract

Relative risk

0.76

95% CI 0.62–0.93

Short-acting beta-blockers vs Usual care
RR 0.76 (95% CI 0.62–0.93)

Further pooled results

OutcomeRR (95% CI)
New-onset tachyarrhythmiasModerate certainty0.37 (0.18–0.78)
90-day mortality · very low certainty0.98 (0.73–1.31)
OutcomeMD (d) (95% CI)
Duration of vasopressorsLow certainty1.04 (0.37–1.72)
ICU LOSVery low certainty−0.75 (−3.43 to 1.93)
Hospital LOSVery low certainty1.03 (−1.92 to 3.98)
Duration of mechanical ventilationVery low certainty−0.10 (−1.25 to 1.05)

Safety

OutcomeRR (95% CI)
Bradycardia episodesVery low certainty3.14 (0.91–14.01)
Hypotension episodesVery low certainty4.74 (1.62–14.01)

Original publication

Impact of Short-Acting Beta-Blockers on the Outcomes of Patients With Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. Published 26 February 2025. doi:10.1097/ccm.0000000000006604

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.